Profil
Moira Daniels worked as a Director-Legal Affairs at Jubilant DraxImage, Inc. from 2005 to 2013.
She also worked as a Vice President-Regulatory Affairs at AstraZeneca PLC from 2001 to 2013 and at UCB Pharma SA (Belgium) from 2015 to 2019.
In 2019, she was the Head-Regulatory Affair & Quality Assurance at Liminal BioSciences, Inc. Ms. Daniels completed her undergraduate degree and MBA from Henley Management College.
Anciens postes connus de Moira Daniels
| Sociétés | Poste | Fin |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | Conseiller Juridique Général | 01/09/2021 |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Conseiller Juridique Général | 01/11/2019 |
| ASTRAZENECA PLC | Conseiller Juridique Général | 01/10/2013 |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Conseiller Juridique Général | 01/07/2013 |
Formation de Moira Daniels
| Henley Management College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Health Technology |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
